CIK: 0001017645
Total reported value
$2.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | DLO | DLocal Limited | Stock-Other | 22.97% | +5.20% | — | |
| 2 | CHYM | Chime Financial Inc-cl A | Stock-Other | 18.63% | -0.10% | +10.68% | |
| 3 | XPEV | Xp INC Class A | Stock-Other | 12.93% | +5.30% | -11.05% | |
| 4 | ALKT | Alkami Technology INC | Stock-Other | 9.63% | +1.56% | — | |
| 5 | ALHC | Alignment Healthcare INC | Stock-Other | 9.05% | -9.05% | EXIT | |
| 6 | RVMD | Revolution Medicines INC | Stock-Healthcare | 7.80% | -4.60% | +13.68% | |
| 7 | PHVS | Pharvaris N.V. | Stock-Other | 7.76% | +2.80% | — | |
| 8 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 5.33% | -2.83% | -36.81% | |
| 9 | NRIX | Nurix Therapeutics INC | Stock-Other | 3.23% | -0.27% | — | |
| 10 | EWCZ | European Wax Center Inc-a | Stock-Other | 1.64% | +1.89% | — | |
| 11 | RSKD | Riskified Ltd. | Stock-Other | 0.92% | +0.05% | — | |
| 12 | GROV | Grove Collaborative Holdings | Stock-Other | 0.09% | +0.06% | — | |
| 13 | ✓ | Stock-Other | 0.01% | — | -99.29% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CHYM | Chime Financial Inc-cl A | +7% | +10.68% | Add |
| 2 | RVMD | Revolution Medicines INC | +4.3% | +13.68% | Add |
| 3 | DLO | DLocal Limited | +3% | — | Unchanged |
| 4 | PHVS | Pharvaris N.V. | +1.7% | — | Unchanged |
| 5 | ALKT | Alkami Technology INC | +0.7% | — | Unchanged |
| 6 | RSKD | Riskified Ltd. | +0.2% | — | Unchanged |
| 7 | EWCZ | European Wax Center Inc-a | +0.1% | — | Unchanged |
| 8 | GROV | Grove Collaborative Holdings | 0% | — | Unchanged |
| 9 | XPEV | Xp INC Class A | -1.5% | -11.05% | Trim |
| 10 | 260 | Centessa Pharmaceuticals-adr | -1.7% | -36.81% | Trim |
| 11 | ✓ | -3.2% | -99.29% | Trim | |
| 12 | ALHC | Alignment Healthcare INC | -3.7% | -45.78% | Trim |
| 13 | AKRO | Akero Therapeutics INC | — | EXIT | Sold out |
| 14 | NRIX | Nurix Therapeutics INC | — | NEW | New buy |
| 15 | RPRX | Royalty Pharma plc | — | EXIT | Sold out |
| 16 | ADAG | Adagene Inc-adr | — | EXIT | Sold out |
| 17 | ALMS | Alumis INC | — | EXIT | Sold out |